No. 442: Snoopy and Gandhi in ‘The Twilight Zone’ – and puppy love at the SBDC
Fall for it: Don’t let the thermometer fool you – it’s actually autumn, dear readers, and we’ll be bundled up soon enough! Whatever the hell Mother Nature is smoking,…
National Institutes of Health
‘Early’ $2M grant cheers ambitious depression study
By GREGORY ZELLER // A seven-digit federal grant will help a Stony Brook University researcher develop new treatment protocols for adolescents suffering from depression. More than just “feeling sad” because…
With pilot run ending, top marks for LI Bioscience Hub
By GREGORY ZELLER // The Long Island Bioscience Hub is making the grade, according to a report card prepared by independent evaluators. Since launching in 2015, the LIBH – a…
See you in September (not): Stanley stuns SBU, SUNY
By GREGORY ZELLER // From the Didn’t See That Coming file comes the sudden departure of Stony Brook University President Samuel Stanley Jr., who has resigned his position and will…
Feinstein stimulates talk of an arthritis breakthrough
By GREGORY ZELLER // An encouraging new study out of the Feinstein Institute for Medical Research says noninvasive bioelectronic stimulation – administered through the outer ear – can effectively reduce…
How to build a better med-tech entrepreneur
By GREGORY ZELLER // One of this generation’s commercialization aces says Long Island’s next crop of healthcare visionaries has got the goods. They’re not ready for prime time. Only some…
No. 371: On Hollywood Whisky, organic sweeteners, zero-calorie chocolate and other tasty matters
Welcome to Friday: You’ve done it, dear reader – the first full workweek of 2019 is just about in the books, and a very welcomed weekend is upon us….
NIH gets behind new Feinstein Institute sepsis study
By GREGORY ZELLER // A five-year National Institutes of Health grant will pack the protein into a new Long Island sepsis study. Monowar Aziz, an assistant professor at the Manhasset-based…
NIH to Feinstein: Stick out that chest (bioelectrically)
By GREGORY ZELLER // With new treatments for obesity, heart failure and a host of other conditions in sight, a Feinstein Institute researcher will zero in on specific abdominal targets…
At LineaRX, putting the horsepower behind the CAR T
By GREGORY ZELLER // Marking a big step in the war against cancer, a Stony Brook-based startup has initiated pre-clinical development of a non-viral, plasmid-free chimeric antigen receptor modified T-cell…
At NYIT, a new doctorate in the house (and first PhD)
By GREGORY ZELLER // Doctor of Philosophy, we presume? And at the New York Institute of Technology, we presume correctly, now that NYIT has introduced its first-ever PhD program, joining…
In blockchain, best chance to secure scientific data
By HENRY FOLEY // At a recent speech in Virginia, Attorney General Jeff Sessions proclaimed that undocumented immigrants in Arizona were more likely to go to jail than U.S. citizens….
Feinstein prof snags $3.5M for bladder-cancer effort
By GREGORY ZELLER // The National Institutes of Health is backing a Long Island-based researcher’s efforts to develop a first-of-its-kind care program for post-surgical bladder cancer patients. Michael Diefenbach, a…
Veteran, rookie SBU researchers earn major honors
By GREGORY ZELLER // Two Stony Brook University researchers – one with an extended résumé of scientific accomplishments, one just warming up – received some major recognition this week. R….
Heavy-hitting LI BioMentor Initiative makes it official
By GREGORY ZELLER // A high-octane effort to unite regional bioentrepreneurs with qualified business mentors has formally launched – though the Long Island BioMentor Initiative is already quite busy. The…